Access cutting-edge uveal melanoma treatment through this clinical trial at a research site in Riverside. Study-provided care at no cost to qualified participants.
Access uveal melanoma specialists in Riverside at no cost
This study follows strict safety protocols and ethical guidelines
All study-related uveal melanoma treatment provided free
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)
Sponsor: IDEAYA Biosciences
Check if you qualify for this uveal melanoma clinical trial in Riverside, CA
If you're searching for uveal melanoma treatment options in Riverside, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Riverside research site is actively enrolling participants for this clinical trial. You'll receive care from experienced uveal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.